Cibc Asset Management Inc Novo Nordisk A S Transaction History

Cibc Asset Management Inc

$25.9 Billion
Q2 2024

A detailed history of Cibc Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Cibc Asset Management Inc holds 67,064 shares of NVO stock, worth $7.99 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

67,064

Previous 70,093 4.32%

Holding current value

$7.99 Million

Previous $9 Million 6.37%

% of portfolio

0.04%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$122.71 - $146.91 $371,688 - $444,990	-3,029 Reduced 4.32%	67,064 $9.57 Million
Q1 2024 May 09, 2024	SELL	$102.11 - $135.92 $27,569 - $36,698	-270 Reduced 0.38%	70,093 $9 Million
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $25,982 - $31,213	-296 Reduced 0.42%	70,363 $7.28 Million
Q3 2023 Oct 30, 2023	BUY	$90.94 - $199.54 $3.22 Million - $7.06 Million	35,400 Added 100.4%	70,659 $6.43 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $1.52 Million - $1.69 Million	9,773 Added 38.35%	35,259 $5.71 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $184,349 - $221,682	-1,393 Reduced 5.18%	25,486 $4.06 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $223,969 - $295,560	-2,184 Reduced 7.51%	26,879 $3.64 Million
Q3 2022 Nov 03, 2022	BUY	$95.28 - $116.93 $20,580 - $25,256	216 Added 0.75%	29,063 $2.9 Million
Q2 2022 Aug 09, 2022	SELL	$103.24 - $121.81 $527,866 - $622,814	-5,113 Reduced 15.06%	28,847 $3.21 Million
Q1 2022 May 06, 2022	BUY	$93.1 - $112.54 $2.91 Million - $3.52 Million	31,239 Added 1148.07%	33,960 $3.77 Million
Q4 2021 Feb 08, 2022	BUY	$95.88 - $117.08 $17,450 - $21,308	182 Added 7.17%	2,721 $305,000
Q3 2021 Nov 09, 2021	SELL	$84.42 - $106.62 $35,709 - $45,100	-423 Reduced 14.28%	2,539 $244,000
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $1.98 Million - $2.48 Million	-29,300 Reduced 90.82%	2,962 $248,000
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $1,676 - $1,895	25 Added 0.08%	32,262 $2.18 Million
Q4 2020 Feb 03, 2021	SELL	$63.89 - $73.8 $2.33 Million - $2.69 Million	-36,435 Reduced 53.06%	32,237 $2.25 Million
Q3 2020 Nov 05, 2020	SELL	$63.69 - $70.22 $148,079 - $163,261	-2,325 Reduced 3.27%	68,672 $4.77 Million
Q2 2020 Jul 28, 2020	SELL	$58.54 - $67.94 $52,978 - $61,485	-905 Reduced 1.26%	70,997 $4.65 Million
Q1 2020 Apr 30, 2020	SELL	$49.46 - $64.78 $647,431 - $847,970	-13,090 Reduced 15.4%	71,902 $4.33 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $127,043 - $148,446	-2,548 Reduced 2.91%	84,992 $4.92 Million
Q3 2019 Oct 30, 2019	SELL	$47.54 - $53.43 $123,604 - $138,918	-2,600 Reduced 2.88%	87,540 $4.53 Million
Q2 2019 Aug 05, 2019	SELL	$46.79 - $52.47 $8.41 Million - $9.43 Million	-179,799 Reduced 66.61%	90,140 $4.6 Million
Q1 2019 May 06, 2019	BUY	$46.36 - $52.63 $1.02 Million - $1.16 Million	22,108 Added 8.92%	269,939 $14.1 Million
Q4 2018 Feb 12, 2019	BUY	$41.54 - $47.25 $10.3 Million - $11.7 Million	247,831 New	247,831 $11.4 Million

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $269B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Novo Nordisk A S Transaction History